1.0South Africa Gazettehttps://southafricagazette.comshadminhttps://southafricagazette.com/author/shadmin-s/rich600338<blockquote class="wp-embedded-content" data-secret="ZsBJsHloZu"><a href="https://southafricagazette.com/aim-immunotech-announces-late-breaking-presentation-at-the-international-conference-on-antiviral-research-regarding-ampligen-as-a-potential-therapy-against-ebola-virus-disease/">AIM ImmunoTech Announces Late-Breaking Presentation at the International Conference on Antiviral Research Regarding Ampligen as a Potential Therapy Against Ebola Virus Disease</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://southafricagazette.com/aim-immunotech-announces-late-breaking-presentation-at-the-international-conference-on-antiviral-research-regarding-ampligen-as-a-potential-therapy-against-ebola-virus-disease/embed/#?secret=ZsBJsHloZu" width="600" height="338" title="“AIM ImmunoTech Announces Late-Breaking Presentation at the International Conference on Antiviral Research Regarding Ampligen as a Potential Therapy Against Ebola Virus Disease” — South Africa Gazette" data-secret="ZsBJsHloZu" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> Growing body of data supports Ampligen’s potential as both a prophylactic and an early-onset therapy against human Ebola virus disease outbreaks OCALA, Fla., March 16, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of […]https://ci5.googleusercontent.com/proxy/QtFKTV1bh_fIXU1ZissgXt94kDNm3M3KCmuFcGkR5p_WpIUmH8lIqyDO75DtjVLAAa8UhvXg9M0u-lxawhA5c5-SadwuDPZiAVhNwJd_8ce-19fbJvX5hBwNVF7p31Z2Kp4q_gsKUl8uw5xNfzbEMbQ2JAX9i32OhwNAnQccZbvaiK005HLb0GSxPXtvF4M=s0-d-e1-ft#https://ml.globenewswire.com/media/NTM2NWIyMTYtOTFkNy00MzExLWFhZGYtZGNhYzIwMjY4NTVlLTEwMzQ3MzU=/tiny/AIM-ImmunoTech-Inc-.png